List of Definitive Healthcare Cohort Builder Customers
Framingham, 1701, MA,
United States
Since 2010, our global team of researchers has been studying Definitive Healthcare Cohort Builder customers around the world, aggregating massive amounts of data points that form the basis of our forecast assumptions and perhaps the rise and fall of certain vendors and their products on a quarterly basis.
Each quarter our research team identifies companies that have purchased Definitive Healthcare Cohort Builder for Analytics and BI from public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources, including the customer size, industry, location, implementation status, partner involvement, LOB Key Stakeholders and related IT decision-makers contact details.
Companies using Definitive Healthcare Cohort Builder for Analytics and BI include: Siemens Healthineers, a Germany based Life Sciences organisation with 71400 employees and revenues of $23.50 billion, Boehringer Ingelheim USA, a United States based Life Sciences organisation with 10000 employees and revenues of $4.50 billion, Abiomed, a United States based Life Sciences organisation with 2003 employees and revenues of $1.03 billion, Brasseler USA, a United States based Manufacturing organisation with 300 employees and revenues of $50.0 million and many others.
Contact us if you need a completed and verified list of companies using Definitive Healthcare Cohort Builder, including the breakdown by industry (21 Verticals), Geography (Region, Country, State, City), Company Size (Revenue, Employees, Asset) and related IT Decision Makers, Key Stakeholders, business and technology executives responsible for the software purchases.
The Definitive Healthcare Cohort Builder customer wins are being incorporated in our Enterprise Applications Buyer Insight and Technographics Customer Database which has over 100 data fields that detail company usage of software systems and their digital transformation initiatives. Apps Run The World wants to become your No. 1 technographic data source!
Apply Filters For Customers
| Logo | Customer | Industry | Empl. | Revenue | Country | Vendor | Application | Category | When | SI | Insight |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Abiomed | Life Sciences | 2003 | $1.0B | United States | Definitive Healthcare | Definitive Healthcare Cohort Builder | Analytics and BI | 2017 | n/a |
In 2017, Abiomed implemented Definitive Healthcare Cohort Builder. The deployment designated Definitive Healthcare Cohort Builder as the organization’s Analytics and BI tool for cohort analysis, custom reporting, and segmentation workflows.
The implementation centered on cohort definition and custom data reports, with configuration focused on attribute-based segmentation, ad hoc query support, and dashboarding for comparative cohort views. Abiomed leveraged the Cohort Builder capabilities to refine report filters, expand data slices, and produce exports for downstream analysis and commercial planning.
Operationally the solution was embedded into commercial analytics and market intelligence workflows for the life sciences organization, supporting provider and organization level segmentation and targeted reporting across relevant business functions. The Definitive Healthcare Cohort Builder implementation served as a centralized analytics layer for teams needing repeatable cohort construction and tailored reporting.
Governance and ongoing configuration relied on direct vendor-to-customer collaboration, with Abiomed staff working one on one with Definitive Healthcare representatives to iterate on report design. Hailey Mccall at Abiomed described the direct line to people pulling custom data reports as a huge help, noting representatives provided suggestions to make reports more accurate or more expansive and calling the support experience absolutely amazing.
|
 |
Boehringer Ingelheim USA | Life Sciences | 10000 | $4.5B | United States | Definitive Healthcare | Definitive Healthcare Cohort Builder | Analytics and BI | 2017 | n/a |
In 2017, Boehringer Ingelheim USA implemented Definitive Healthcare Cohort Builder as an Analytics and BI application to combine commercial claims intelligence with broad provider data for commercial segmentation. Definitive Healthcare Cohort Builder was used to support targeting across the companys diabetes, respiratory, and cardiovascular product lines by surfacing the interface between primary care and specialists and enabling more granular cohort definitions.
The implementation emphasized cohort definition, provider specialty mapping, and provider network analysis capabilities to generate refined targeting lists and tailored message segmentation. Functional workflows implemented in Definitive Healthcare Cohort Builder included cohort creation based on claims signals, provider relationship analysis between primary care and specialists, and list export for commercial outreach and account planning.
Operational use was centered in the United States commercial organization, with National Account and GPO teams leveraging the platform for account-level targeting and message refinement. Governance focused on centralized use of combined claims and provider intelligence for commercial targeting, and stakeholders reported that the additional insights from linking commercial claims intelligence with broad provider data enabled more specific targeting lists and messaging for individual prescribers and provider segments.
|
 |
Brasseler USA | Manufacturing | 300 | $50M | United States | Definitive Healthcare | Definitive Healthcare Cohort Builder | Analytics and BI | 2016 | n/a |
In 2016 Brasseler USA implemented Definitive Healthcare Cohort Builder to strengthen Analytics and BI capabilities for procedure-level market intelligence and product planning. The deployment centered on cohort definition and procedure analytics to surface growth signals related to surgical procedures and device usage, aligning clinical procedure datasets with commercial planning needs, and Rachelle Ferrara Senior Director GM Brasseler Surgical noted that Definitive data allows the company to capture what its customers needs are moving forward.
Configuration work focused on custom cohort definitions, procedure-level filtering, temporal trend analysis, and visualization and reporting to support product development decision making. Definitive Healthcare Cohort Builder was configured to produce repeatable cohorts and dashboards for cross-functional review, enabling analysts to iterate on cohort criteria and export analytical outputs for downstream planning workflows.
Operational scope included product development and planning teams within Brasseler USA, where the Cohort Builder informed product roadmaps and opportunity identification. Governance emphasized repeatable cohort definitions and review cycles to surface growth opportunities, reflecting the stated goal of understanding where growth exists and capturing evolving customer needs.
|
 |
|
Life Sciences | 71400 | $23.5B | Germany | Definitive Healthcare | Definitive Healthcare Cohort Builder | Analytics and BI | 2017 | n/a |
|
Buyer Intent: Companies Evaluating Definitive Healthcare Cohort Builder
Discover Software Buyers actively Evaluating Enterprise Applications
| Logo | Company | Industry | Employees | Revenue | Country | Evaluated | ||
|---|---|---|---|---|---|---|---|---|
| No data found | ||||||||